nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Sinusitis—Doxorubicin—stomach cancer	0.000638	0.000638	CcSEcCtD
Anagrelide—Dizziness—Fluorouracil—stomach cancer	0.000636	0.000636	CcSEcCtD
Anagrelide—Visual impairment—Epirubicin—stomach cancer	0.000636	0.000636	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—stomach cancer	0.000635	0.000635	CcSEcCtD
Anagrelide—Rash—Irinotecan—stomach cancer	0.000634	0.000634	CcSEcCtD
Anagrelide—Dermatitis—Irinotecan—stomach cancer	0.000633	0.000633	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000633	0.000633	CcSEcCtD
Anagrelide—Chills—Methotrexate—stomach cancer	0.000632	0.000632	CcSEcCtD
Anagrelide—Headache—Irinotecan—stomach cancer	0.00063	0.00063	CcSEcCtD
Anagrelide—Hypotension—Capecitabine—stomach cancer	0.000628	0.000628	CcSEcCtD
Anagrelide—Insomnia—Docetaxel—stomach cancer	0.000628	0.000628	CcSEcCtD
Anagrelide—Paraesthesia—Docetaxel—stomach cancer	0.000624	0.000624	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—stomach cancer	0.000623	0.000623	CcSEcCtD
Anagrelide—Dyspnoea—Docetaxel—stomach cancer	0.000619	0.000619	CcSEcCtD
Anagrelide—Somnolence—Docetaxel—stomach cancer	0.000618	0.000618	CcSEcCtD
Anagrelide—Eye disorder—Epirubicin—stomach cancer	0.000616	0.000616	CcSEcCtD
Anagrelide—Tinnitus—Epirubicin—stomach cancer	0.000615	0.000615	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—stomach cancer	0.000613	0.000613	CcSEcCtD
Anagrelide—Haemoglobin—Doxorubicin—stomach cancer	0.000613	0.000613	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000613	0.000613	CcSEcCtD
Anagrelide—Cardiac disorder—Epirubicin—stomach cancer	0.000612	0.000612	CcSEcCtD
Anagrelide—Vomiting—Fluorouracil—stomach cancer	0.000612	0.000612	CcSEcCtD
Anagrelide—Rhinitis—Doxorubicin—stomach cancer	0.000612	0.000612	CcSEcCtD
Anagrelide—Dyspepsia—Docetaxel—stomach cancer	0.000612	0.000612	CcSEcCtD
Anagrelide—Haemorrhage—Doxorubicin—stomach cancer	0.00061	0.00061	CcSEcCtD
Anagrelide—Hepatitis—Doxorubicin—stomach cancer	0.00061	0.00061	CcSEcCtD
Anagrelide—Insomnia—Capecitabine—stomach cancer	0.000608	0.000608	CcSEcCtD
Anagrelide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000607	0.000607	CcSEcCtD
Anagrelide—Rash—Fluorouracil—stomach cancer	0.000607	0.000607	CcSEcCtD
Anagrelide—Dermatitis—Fluorouracil—stomach cancer	0.000606	0.000606	CcSEcCtD
Anagrelide—Pharyngitis—Doxorubicin—stomach cancer	0.000606	0.000606	CcSEcCtD
Anagrelide—Paraesthesia—Capecitabine—stomach cancer	0.000604	0.000604	CcSEcCtD
Anagrelide—Decreased appetite—Docetaxel—stomach cancer	0.000604	0.000604	CcSEcCtD
Anagrelide—Headache—Fluorouracil—stomach cancer	0.000603	0.000603	CcSEcCtD
Anagrelide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000603	0.000603	CcSEcCtD
Anagrelide—Oedema peripheral—Doxorubicin—stomach cancer	0.000601	0.000601	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.0006	0.0006	CcSEcCtD
Anagrelide—Connective tissue disorder—Doxorubicin—stomach cancer	0.0006	0.0006	CcSEcCtD
Anagrelide—Dyspnoea—Capecitabine—stomach cancer	0.0006	0.0006	CcSEcCtD
Anagrelide—Fatigue—Docetaxel—stomach cancer	0.000599	0.000599	CcSEcCtD
Anagrelide—Urethral disorder—Doxorubicin—stomach cancer	0.000598	0.000598	CcSEcCtD
Anagrelide—Nausea—Irinotecan—stomach cancer	0.000597	0.000597	CcSEcCtD
Anagrelide—Mediastinal disorder—Epirubicin—stomach cancer	0.000594	0.000594	CcSEcCtD
Anagrelide—Constipation—Docetaxel—stomach cancer	0.000594	0.000594	CcSEcCtD
Anagrelide—Pain—Docetaxel—stomach cancer	0.000594	0.000594	CcSEcCtD
Anagrelide—Back pain—Methotrexate—stomach cancer	0.000593	0.000593	CcSEcCtD
Anagrelide—Dyspepsia—Capecitabine—stomach cancer	0.000592	0.000592	CcSEcCtD
Anagrelide—Chills—Epirubicin—stomach cancer	0.000592	0.000592	CcSEcCtD
Anagrelide—Arrhythmia—Epirubicin—stomach cancer	0.000589	0.000589	CcSEcCtD
Anagrelide—Visual impairment—Doxorubicin—stomach cancer	0.000588	0.000588	CcSEcCtD
Anagrelide—Decreased appetite—Capecitabine—stomach cancer	0.000585	0.000585	CcSEcCtD
Anagrelide—Alopecia—Epirubicin—stomach cancer	0.000583	0.000583	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000581	0.000581	CcSEcCtD
Anagrelide—Fatigue—Capecitabine—stomach cancer	0.00058	0.00058	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—stomach cancer	0.000578	0.000578	CcSEcCtD
Anagrelide—Constipation—Capecitabine—stomach cancer	0.000575	0.000575	CcSEcCtD
Anagrelide—Pain—Capecitabine—stomach cancer	0.000575	0.000575	CcSEcCtD
Anagrelide—Malnutrition—Epirubicin—stomach cancer	0.000574	0.000574	CcSEcCtD
Anagrelide—Feeling abnormal—Docetaxel—stomach cancer	0.000572	0.000572	CcSEcCtD
Anagrelide—Nausea—Fluorouracil—stomach cancer	0.000572	0.000572	CcSEcCtD
Anagrelide—Eye disorder—Doxorubicin—stomach cancer	0.00057	0.00057	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—stomach cancer	0.000569	0.000569	CcSEcCtD
Anagrelide—Tinnitus—Doxorubicin—stomach cancer	0.000569	0.000569	CcSEcCtD
Anagrelide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000568	0.000568	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—stomach cancer	0.000567	0.000567	CcSEcCtD
Anagrelide—Cardiac disorder—Doxorubicin—stomach cancer	0.000566	0.000566	CcSEcCtD
Anagrelide—Flatulence—Epirubicin—stomach cancer	0.000566	0.000566	CcSEcCtD
Anagrelide—Tension—Epirubicin—stomach cancer	0.000563	0.000563	CcSEcCtD
Anagrelide—Nervousness—Epirubicin—stomach cancer	0.000558	0.000558	CcSEcCtD
Anagrelide—Back pain—Epirubicin—stomach cancer	0.000555	0.000555	CcSEcCtD
Anagrelide—Feeling abnormal—Capecitabine—stomach cancer	0.000554	0.000554	CcSEcCtD
Anagrelide—Malaise—Methotrexate—stomach cancer	0.000553	0.000553	CcSEcCtD
Anagrelide—Muscle spasms—Epirubicin—stomach cancer	0.000552	0.000552	CcSEcCtD
Anagrelide—Gastrointestinal pain—Capecitabine—stomach cancer	0.00055	0.00055	CcSEcCtD
Anagrelide—Mediastinal disorder—Doxorubicin—stomach cancer	0.00055	0.00055	CcSEcCtD
Anagrelide—Body temperature increased—Docetaxel—stomach cancer	0.000549	0.000549	CcSEcCtD
Anagrelide—Abdominal pain—Docetaxel—stomach cancer	0.000549	0.000549	CcSEcCtD
Anagrelide—Chills—Doxorubicin—stomach cancer	0.000548	0.000548	CcSEcCtD
Anagrelide—Arrhythmia—Doxorubicin—stomach cancer	0.000545	0.000545	CcSEcCtD
Anagrelide—Vision blurred—Epirubicin—stomach cancer	0.000541	0.000541	CcSEcCtD
Anagrelide—Alopecia—Doxorubicin—stomach cancer	0.000539	0.000539	CcSEcCtD
Anagrelide—Cough—Methotrexate—stomach cancer	0.000535	0.000535	CcSEcCtD
Anagrelide—Urticaria—Capecitabine—stomach cancer	0.000534	0.000534	CcSEcCtD
Anagrelide—Ill-defined disorder—Epirubicin—stomach cancer	0.000533	0.000533	CcSEcCtD
Anagrelide—Abdominal pain—Capecitabine—stomach cancer	0.000532	0.000532	CcSEcCtD
Anagrelide—Body temperature increased—Capecitabine—stomach cancer	0.000532	0.000532	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—stomach cancer	0.000532	0.000532	CcSEcCtD
Anagrelide—Malnutrition—Doxorubicin—stomach cancer	0.000531	0.000531	CcSEcCtD
Anagrelide—Anaemia—Epirubicin—stomach cancer	0.000531	0.000531	CcSEcCtD
Anagrelide—Flatulence—Doxorubicin—stomach cancer	0.000523	0.000523	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—stomach cancer	0.000522	0.000522	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—stomach cancer	0.000522	0.000522	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—stomach cancer	0.000522	0.000522	CcSEcCtD
Anagrelide—Tension—Doxorubicin—stomach cancer	0.000521	0.000521	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000519	0.000519	CcSEcCtD
Anagrelide—Malaise—Epirubicin—stomach cancer	0.000518	0.000518	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—stomach cancer	0.000516	0.000516	CcSEcCtD
Anagrelide—Nervousness—Doxorubicin—stomach cancer	0.000516	0.000516	CcSEcCtD
Anagrelide—Syncope—Epirubicin—stomach cancer	0.000515	0.000515	CcSEcCtD
Anagrelide—Back pain—Doxorubicin—stomach cancer	0.000514	0.000514	CcSEcCtD
Anagrelide—Muscle spasms—Doxorubicin—stomach cancer	0.000511	0.000511	CcSEcCtD
Anagrelide—Palpitations—Epirubicin—stomach cancer	0.000507	0.000507	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—stomach cancer	0.000505	0.000505	CcSEcCtD
Anagrelide—Loss of consciousness—Epirubicin—stomach cancer	0.000505	0.000505	CcSEcCtD
Anagrelide—Cough—Epirubicin—stomach cancer	0.000501	0.000501	CcSEcCtD
Anagrelide—Vision blurred—Doxorubicin—stomach cancer	0.000501	0.000501	CcSEcCtD
Anagrelide—Asthenia—Docetaxel—stomach cancer	0.000498	0.000498	CcSEcCtD
Anagrelide—Convulsion—Epirubicin—stomach cancer	0.000497	0.000497	CcSEcCtD
Anagrelide—Infection—Methotrexate—stomach cancer	0.000497	0.000497	CcSEcCtD
Anagrelide—Hypertension—Epirubicin—stomach cancer	0.000496	0.000496	CcSEcCtD
Anagrelide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000493	0.000493	CcSEcCtD
Anagrelide—Pruritus—Docetaxel—stomach cancer	0.000491	0.000491	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—stomach cancer	0.000491	0.000491	CcSEcCtD
Anagrelide—Anaemia—Doxorubicin—stomach cancer	0.000491	0.000491	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—stomach cancer	0.00049	0.00049	CcSEcCtD
Anagrelide—Arthralgia—Epirubicin—stomach cancer	0.000489	0.000489	CcSEcCtD
Anagrelide—Myalgia—Epirubicin—stomach cancer	0.000489	0.000489	CcSEcCtD
Anagrelide—Chest pain—Epirubicin—stomach cancer	0.000489	0.000489	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—stomach cancer	0.000486	0.000486	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000485	0.000485	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—stomach cancer	0.000484	0.000484	CcSEcCtD
Anagrelide—Discomfort—Epirubicin—stomach cancer	0.000483	0.000483	CcSEcCtD
Anagrelide—Asthenia—Capecitabine—stomach cancer	0.000483	0.000483	CcSEcCtD
Anagrelide—Malaise—Doxorubicin—stomach cancer	0.000479	0.000479	CcSEcCtD
Anagrelide—Dry mouth—Epirubicin—stomach cancer	0.000478	0.000478	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—stomach cancer	0.000477	0.000477	CcSEcCtD
Anagrelide—Syncope—Doxorubicin—stomach cancer	0.000476	0.000476	CcSEcCtD
Anagrelide—Pruritus—Capecitabine—stomach cancer	0.000476	0.000476	CcSEcCtD
Anagrelide—Diarrhoea—Docetaxel—stomach cancer	0.000475	0.000475	CcSEcCtD
Anagrelide—Confusional state—Epirubicin—stomach cancer	0.000472	0.000472	CcSEcCtD
Anagrelide—Palpitations—Doxorubicin—stomach cancer	0.000469	0.000469	CcSEcCtD
Anagrelide—Oedema—Epirubicin—stomach cancer	0.000469	0.000469	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—stomach cancer	0.000468	0.000468	CcSEcCtD
Anagrelide—Loss of consciousness—Doxorubicin—stomach cancer	0.000467	0.000467	CcSEcCtD
Anagrelide—Infection—Epirubicin—stomach cancer	0.000466	0.000466	CcSEcCtD
Anagrelide—Cough—Doxorubicin—stomach cancer	0.000464	0.000464	CcSEcCtD
Anagrelide—Shock—Epirubicin—stomach cancer	0.000461	0.000461	CcSEcCtD
Anagrelide—Convulsion—Doxorubicin—stomach cancer	0.00046	0.00046	CcSEcCtD
Anagrelide—Diarrhoea—Capecitabine—stomach cancer	0.00046	0.00046	CcSEcCtD
Anagrelide—Nervous system disorder—Epirubicin—stomach cancer	0.00046	0.00046	CcSEcCtD
Anagrelide—Dizziness—Docetaxel—stomach cancer	0.000459	0.000459	CcSEcCtD
Anagrelide—Thrombocytopenia—Epirubicin—stomach cancer	0.000459	0.000459	CcSEcCtD
Anagrelide—Hypertension—Doxorubicin—stomach cancer	0.000459	0.000459	CcSEcCtD
Anagrelide—Tachycardia—Epirubicin—stomach cancer	0.000457	0.000457	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000456	0.000456	CcSEcCtD
Anagrelide—Skin disorder—Epirubicin—stomach cancer	0.000455	0.000455	CcSEcCtD
Anagrelide—Hyperhidrosis—Epirubicin—stomach cancer	0.000453	0.000453	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—stomach cancer	0.000453	0.000453	CcSEcCtD
Anagrelide—Arthralgia—Doxorubicin—stomach cancer	0.000452	0.000452	CcSEcCtD
Anagrelide—Myalgia—Doxorubicin—stomach cancer	0.000452	0.000452	CcSEcCtD
Anagrelide—Chest pain—Doxorubicin—stomach cancer	0.000452	0.000452	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—stomach cancer	0.00045	0.00045	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000449	0.000449	CcSEcCtD
Anagrelide—Discomfort—Doxorubicin—stomach cancer	0.000447	0.000447	CcSEcCtD
Anagrelide—Anorexia—Epirubicin—stomach cancer	0.000447	0.000447	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—stomach cancer	0.000446	0.000446	CcSEcCtD
Anagrelide—Somnolence—Methotrexate—stomach cancer	0.000445	0.000445	CcSEcCtD
Anagrelide—Dizziness—Capecitabine—stomach cancer	0.000445	0.000445	CcSEcCtD
Anagrelide—Dry mouth—Doxorubicin—stomach cancer	0.000442	0.000442	CcSEcCtD
Anagrelide—Vomiting—Docetaxel—stomach cancer	0.000442	0.000442	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—stomach cancer	0.000441	0.000441	CcSEcCtD
Anagrelide—Rash—Docetaxel—stomach cancer	0.000438	0.000438	CcSEcCtD
Anagrelide—Hypotension—Epirubicin—stomach cancer	0.000438	0.000438	CcSEcCtD
Anagrelide—Dermatitis—Docetaxel—stomach cancer	0.000438	0.000438	CcSEcCtD
Anagrelide—Confusional state—Doxorubicin—stomach cancer	0.000437	0.000437	CcSEcCtD
Anagrelide—Decreased appetite—Methotrexate—stomach cancer	0.000435	0.000435	CcSEcCtD
Anagrelide—Headache—Docetaxel—stomach cancer	0.000435	0.000435	CcSEcCtD
Anagrelide—Oedema—Doxorubicin—stomach cancer	0.000434	0.000434	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000432	0.000432	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—stomach cancer	0.000432	0.000432	CcSEcCtD
Anagrelide—Infection—Doxorubicin—stomach cancer	0.000431	0.000431	CcSEcCtD
Anagrelide—Pain—Methotrexate—stomach cancer	0.000428	0.000428	CcSEcCtD
Anagrelide—Vomiting—Capecitabine—stomach cancer	0.000428	0.000428	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000427	0.000427	CcSEcCtD
Anagrelide—Shock—Doxorubicin—stomach cancer	0.000427	0.000427	CcSEcCtD
Anagrelide—Nervous system disorder—Doxorubicin—stomach cancer	0.000425	0.000425	CcSEcCtD
Anagrelide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000424	0.000424	CcSEcCtD
Anagrelide—Rash—Capecitabine—stomach cancer	0.000424	0.000424	CcSEcCtD
Anagrelide—Insomnia—Epirubicin—stomach cancer	0.000424	0.000424	CcSEcCtD
Anagrelide—Dermatitis—Capecitabine—stomach cancer	0.000424	0.000424	CcSEcCtD
Anagrelide—Tachycardia—Doxorubicin—stomach cancer	0.000423	0.000423	CcSEcCtD
Anagrelide—Headache—Capecitabine—stomach cancer	0.000421	0.000421	CcSEcCtD
Anagrelide—Skin disorder—Doxorubicin—stomach cancer	0.000421	0.000421	CcSEcCtD
Anagrelide—Paraesthesia—Epirubicin—stomach cancer	0.000421	0.000421	CcSEcCtD
Anagrelide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000419	0.000419	CcSEcCtD
Anagrelide—Dyspnoea—Epirubicin—stomach cancer	0.000418	0.000418	CcSEcCtD
Anagrelide—Somnolence—Epirubicin—stomach cancer	0.000417	0.000417	CcSEcCtD
Anagrelide—Anorexia—Doxorubicin—stomach cancer	0.000413	0.000413	CcSEcCtD
Anagrelide—Nausea—Docetaxel—stomach cancer	0.000413	0.000413	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—stomach cancer	0.000413	0.000413	CcSEcCtD
Anagrelide—Dyspepsia—Epirubicin—stomach cancer	0.000412	0.000412	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000409	0.000409	CcSEcCtD
Anagrelide—Decreased appetite—Epirubicin—stomach cancer	0.000407	0.000407	CcSEcCtD
Anagrelide—Hypotension—Doxorubicin—stomach cancer	0.000405	0.000405	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000405	0.000405	CcSEcCtD
Anagrelide—Fatigue—Epirubicin—stomach cancer	0.000404	0.000404	CcSEcCtD
Anagrelide—Pain—Epirubicin—stomach cancer	0.000401	0.000401	CcSEcCtD
Anagrelide—Constipation—Epirubicin—stomach cancer	0.000401	0.000401	CcSEcCtD
Anagrelide—Nausea—Capecitabine—stomach cancer	0.0004	0.0004	CcSEcCtD
Anagrelide—Urticaria—Methotrexate—stomach cancer	0.000398	0.000398	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—stomach cancer	0.000396	0.000396	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—stomach cancer	0.000396	0.000396	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000395	0.000395	CcSEcCtD
Anagrelide—Insomnia—Doxorubicin—stomach cancer	0.000392	0.000392	CcSEcCtD
Anagrelide—Paraesthesia—Doxorubicin—stomach cancer	0.000389	0.000389	CcSEcCtD
Anagrelide—Dyspnoea—Doxorubicin—stomach cancer	0.000387	0.000387	CcSEcCtD
Anagrelide—Feeling abnormal—Epirubicin—stomach cancer	0.000386	0.000386	CcSEcCtD
Anagrelide—Somnolence—Doxorubicin—stomach cancer	0.000385	0.000385	CcSEcCtD
Anagrelide—Gastrointestinal pain—Epirubicin—stomach cancer	0.000383	0.000383	CcSEcCtD
Anagrelide—Dyspepsia—Doxorubicin—stomach cancer	0.000382	0.000382	CcSEcCtD
Anagrelide—Decreased appetite—Doxorubicin—stomach cancer	0.000377	0.000377	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000374	0.000374	CcSEcCtD
Anagrelide—Fatigue—Doxorubicin—stomach cancer	0.000374	0.000374	CcSEcCtD
Anagrelide—Urticaria—Epirubicin—stomach cancer	0.000372	0.000372	CcSEcCtD
Anagrelide—Pain—Doxorubicin—stomach cancer	0.000371	0.000371	CcSEcCtD
Anagrelide—Constipation—Doxorubicin—stomach cancer	0.000371	0.000371	CcSEcCtD
Anagrelide—Body temperature increased—Epirubicin—stomach cancer	0.00037	0.00037	CcSEcCtD
Anagrelide—Abdominal pain—Epirubicin—stomach cancer	0.00037	0.00037	CcSEcCtD
Anagrelide—Asthenia—Methotrexate—stomach cancer	0.000359	0.000359	CcSEcCtD
Anagrelide—Feeling abnormal—Doxorubicin—stomach cancer	0.000357	0.000357	CcSEcCtD
Anagrelide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000355	0.000355	CcSEcCtD
Anagrelide—Pruritus—Methotrexate—stomach cancer	0.000354	0.000354	CcSEcCtD
Anagrelide—Urticaria—Doxorubicin—stomach cancer	0.000344	0.000344	CcSEcCtD
Anagrelide—Abdominal pain—Doxorubicin—stomach cancer	0.000343	0.000343	CcSEcCtD
Anagrelide—Body temperature increased—Doxorubicin—stomach cancer	0.000343	0.000343	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—stomach cancer	0.000343	0.000343	CcSEcCtD
Anagrelide—Asthenia—Epirubicin—stomach cancer	0.000336	0.000336	CcSEcCtD
Anagrelide—Pruritus—Epirubicin—stomach cancer	0.000332	0.000332	CcSEcCtD
Anagrelide—Dizziness—Methotrexate—stomach cancer	0.000331	0.000331	CcSEcCtD
Anagrelide—Diarrhoea—Epirubicin—stomach cancer	0.000321	0.000321	CcSEcCtD
Anagrelide—Vomiting—Methotrexate—stomach cancer	0.000318	0.000318	CcSEcCtD
Anagrelide—Rash—Methotrexate—stomach cancer	0.000316	0.000316	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—stomach cancer	0.000315	0.000315	CcSEcCtD
Anagrelide—Headache—Methotrexate—stomach cancer	0.000314	0.000314	CcSEcCtD
Anagrelide—Asthenia—Doxorubicin—stomach cancer	0.000311	0.000311	CcSEcCtD
Anagrelide—Dizziness—Epirubicin—stomach cancer	0.00031	0.00031	CcSEcCtD
Anagrelide—Pruritus—Doxorubicin—stomach cancer	0.000307	0.000307	CcSEcCtD
Anagrelide—Vomiting—Epirubicin—stomach cancer	0.000298	0.000298	CcSEcCtD
Anagrelide—Nausea—Methotrexate—stomach cancer	0.000297	0.000297	CcSEcCtD
Anagrelide—Diarrhoea—Doxorubicin—stomach cancer	0.000297	0.000297	CcSEcCtD
Anagrelide—Rash—Epirubicin—stomach cancer	0.000295	0.000295	CcSEcCtD
Anagrelide—Dermatitis—Epirubicin—stomach cancer	0.000295	0.000295	CcSEcCtD
Anagrelide—Headache—Epirubicin—stomach cancer	0.000294	0.000294	CcSEcCtD
Anagrelide—Dizziness—Doxorubicin—stomach cancer	0.000287	0.000287	CcSEcCtD
Anagrelide—Nausea—Epirubicin—stomach cancer	0.000278	0.000278	CcSEcCtD
Anagrelide—Vomiting—Doxorubicin—stomach cancer	0.000276	0.000276	CcSEcCtD
Anagrelide—Rash—Doxorubicin—stomach cancer	0.000273	0.000273	CcSEcCtD
Anagrelide—Dermatitis—Doxorubicin—stomach cancer	0.000273	0.000273	CcSEcCtD
Anagrelide—Headache—Doxorubicin—stomach cancer	0.000272	0.000272	CcSEcCtD
Anagrelide—Nausea—Doxorubicin—stomach cancer	0.000258	0.000258	CcSEcCtD
